Telormedix SA Company Profile
Telormedix (www.telormedix.com), founded in October 2007, is a biopharmaceutical company focused on targeted immunity and modulation of the innate immune system for treating cancer and autoimmune diseases. The Companyâs lead product, TMX-101, recently entered a Phase I/II clinical trial for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). In addition, Telormedix is developing two TLR7-targeted molecules, TMX-201 and TMX-202, as a vaccine adjuvant. One of these molecules, TMX-202, has recently been selected for preclinical study for the topical treatment of skin cancers and other indications. The candidate has already successfully completed a number of in vivo studies.
News Articles
In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Johanna Holldack, CEO at Telormedix.
In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Johanna Holldack, CEO at Telormedix.
Telormedix granted IND for Phase II in bladder cancer
Telormedix enrols first patient for Phase II in bladder cancer
Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment
Telormedix, Foamix Win €950K to Develop Foam-Based Skin Cancer Treatment
Telormedix enrolls first patient in phase II bladder cancer trial
Telormedix, a Switzerland-based clinical stage biopharmaceutical company focusing on toll-like receptor 7 (TLR7) small molecules in the treatment of cancer and inflammatory diseases, has recruited the...
Drugs and Medications
None
PubMed Articles
Pharmacokinetics and toxicity of intravesical TMX-101: a preclinical study in pigs.
OBJECTIVE: • To study the pharmacokinetic and toxicity profile of intravesically administered TMX-101, with its active ingredient R-837, a synthetic Toll-like receptor (TLR)-7 agonist, in a pig mo...
Clinical Trials
None
Companies
Telormedix (www.telormedix.com), founded in October 2007, is a biopharmaceutical company focused on targeted immunity and modulation of the innate immune system for treatin...
More Information about "Telormedix SA" on BioPortfolio
We have published hundreds of Telormedix SA news stories on BioPortfolio along with dozens of Telormedix SA Clinical Trials and PubMed Articles about Telormedix SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Telormedix SA Companies in our database. You can also find out about relevant Telormedix SA Drugs and Medications on this site too.
